Iimpawu zoMsebenzi
Umda wokufumanisa : 1.0 ng/ mL ;
Uluhlu lomgca: 1.0-1000.0ng / mL;
I-coefficient yokulungelelanisa yomgca R ≥ 0.990;
Ukuchaneka: ngaphakathi kwe-batch CV ngu ≤ 15%;phakathi kweebhetshi iCV yi ≤ 20%;
Ukuchaneka: ukutenxa okunxulumene neziphumo zokulinganisa akuyi kudlula ± 15% xa i-calibrator yokuchaneka elungiswe ngumgangatho wesizwe weFerritin okanye i-standardized accuracy calibrator ivavanywa.
1. Gcina i-detector buffer ku-2～30℃.Isithinteli sizinzile ukuya kwiinyanga ezili-18.
2. Gcina i-Aehealth Ferritin Rapid Quantitative test cassette kwi-2～30℃, ubomi beshelufu bufikelela kwiinyanga ezili-18.
3. Ikhasethi yovavanyo kufuneka isetyenziswe kwiyure enye emva kokuvula ipakethi.
Intsholongwane yeHepatitis C (HCV) yimvulophu, intsholongwane ye-RNA (9.5 kb) engumtya omnye ophuma kusapho lweFlaviviridae.Ii-genotypes ezintandathu eziphambili kunye noluhlu lwee-subtypes ze-HCV ziye zachongwa.Ibekwe yodwa ngo-1989, i-HCV ngoku iqondwa njengoyena nobangela wotofelo-gazi olunxulumene no-non-A, non-B hepatitis.Esi sifo sibonakaliswe ngefom ebukhali kwaye engapheliyo.Ngaphezu kwe-50% yabantu abosulelekileyo bakhula kakhulu, i-hepatitis engapheliyo esongela ubomi kunye ne-cirrhosis yesibindi kunye ne-hepatocellular carcinomas.Ukususela ngowe-1990 kwaqaliswa ukuhlolwa kwe-anti-HCV ekunikeleni ngegazi, iziganeko zolu sulelo kubantu abatofelwa igazi ziye zancitshiswa kakhulu.Uphononongo lwezonyango lubonisa ukuba isixa esibalulekileyo sabantu abosulelwe yi-HCV baphuhlisa izilwa-buhlungu ukuya kwi-NS5 engeyiyo iprotein yentsholongwane.Kule nto, iimvavanyo zibandakanya ii-antigens ezivela kummandla we-NS5 we-genome yentsholongwane ngaphezu kwe-NS3 (c200), i-NS4 (c200) kunye ne-Core (c22).